Wockhardt recalls over 109,000 bottles of hypertension drug in US

Drugmaker Wockhardt Ltd is recalling 109,744 bottles of a high blood pressure drug in the United States after it failed a dissolution test, the US Food and Drug Administration said.

The recall of metoprolol succinate began in April and was posted on the FDA website late Wednesday. Metoprolol succinate extended release is a cheaper generic form of AstraZeneca Plc's branded drug Toprol.

A Wockhardt spokesman did not immediately respond to a request for comment on Thursday.

Dissolution tests are commonly conducted to check the time taken for the active ingredient in a drug to release into the body, and help predict how the drug performs inside the body.

Recalls of medicines by drugmakers are not uncommon, but Wockhardt is already embroiled in regulatory troubles.

Two of its manufacturing plants were banned last year from exporting to the United States after the FDA found violations of manufacturing standards that the agency believed could compromise the quality of drugs. One of those plants was making metoprolol succinate for the United States.

The FDA website said the recalled lots were manufactured at a Wockhardt plant in Mumbai.

EDITORIAL OF THE DAY

  • Not warnings, total prohibition of smoking is the only answer to restoring citizens’ health

    In a landmark judgment the Supreme Court on Wednesday said the tobacco industry must adhere to government rules requiring stringent health warnings on

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Urs Schoettli

Japan’s seismic shocks raise big questions

In the middle of April the region of Kumamoto on ...

Zehra Naqvi

The flame of hate

Pyre. The name itself evokes a sense of foreboding, casting ...

Bubbles Sabharwal

Whiners and complainers, please exit

We all know WC stands for a water closet, a ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture